TCL6 upregulation was recently associated with ETV6-RUNX1-positive pediatric B-ALL, and patients expressing low levels of TCL6 had lower disease-free survival than patients expressing high levels of TCL6 [21]. This evidence concerns the gene TCL6 and precursor B-cell acute lymphoblastic leukemia.